David Charles Lubner - 23 Nov 2022 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for David Charles Lubner
Issuer symbol
N/A
Transactions as of
23 Nov 2022
Net transactions value
+$24,660
Form type
4
Filing time
28 Nov 2022, 15:03:22 UTC
Previous filing
06 Jul 2022
Next filing
25 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Purchase $24,660 +3,600 $6.85 3,600 23 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.